Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
dc.contributor.author | Lochner A | |
dc.contributor.author | Genade SJ | |
dc.contributor.author | Hattingh SM | |
dc.contributor.author | Marais E | |
dc.contributor.author | van Wyk JMW | |
dc.contributor.author | Huisamen B | |
dc.contributor.author | Moolman JA | |
dc.date.accessioned | 2013-01-23T13:46:35Z | |
dc.date.available | 2013-01-23T13:46:35Z | |
dc.date.issued | 2003 | |
dc.description | Gesondheidswetenskappe | |
dc.description | Geneeskundige Fisiologie | |
dc.description | Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za | |
dc.identifier.citation | Cardiovascular Drugs and Therapy | |
dc.identifier.uri | http://hdl.handle.net/10019.1/76727 | |
dc.publisher | KLUWER ACADEMIC PUBL, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ | |
dc.title | Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK. | |
dc.type | Journal Articles (subsidised) |